Drug Type Synthetic peptide |
Synonyms Avicatonin (JAN/INN) |
Target |
Mechanism CALCRL antagonists(Calcitonin gene-related peptide type 1 receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC147H243N41O46 |
InChIKeyLXAVNEKSFBBDSM-UAUXSXORSA-N |
CAS Registry103451-84-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09771 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 3 | JP | - | |
Inflammation | Phase 3 | - | - | |
Osteoporosis, Postmenopausal | Phase 3 | JP | - | |
Pain | Phase 3 | JP | - | |
Pain | Phase 3 | - | - |